The virus hasn't become stronger. We've become weaker.
In the autumn of 2026, Brazil finds itself confronting a familiar adversary made more dangerous by a quieter crisis: not the virus itself, but the erosion of the collective will to resist it. With 506 confirmed influenza deaths by late May and vaccination coverage barely reaching 38.5% of its target, the country is learning again that a disease's power is shaped as much by human choices as by biology. The story of a thirteen-year-old boy in São Paulo state, who moved from body aches to a ventilator in a matter of days, places a human face on what statistics alone cannot fully hold.
- A surge of 136 confirmed influenza deaths in just the final two weeks of May signals not only a worsening outbreak but a healthcare system struggling to keep pace with its own diagnostic backlog.
- More than 1,300 respiratory deaths remain without a confirmed viral cause, meaning the true scale of the crisis is almost certainly larger than official numbers suggest.
- Brazil's flu vaccination campaign closed with its worst coverage since 2021 — only 38.5% of a 90% goal — as pandemic-era vaccine distrust continues to leave the most vulnerable populations exposed.
- Doctors stress the virus has not grown more lethal; what has changed is the population's readiness, with early seasonal circulation arriving before communities had built even modest immunological defenses.
- Public health officials are now weighing how to rebuild confidence in routine vaccination as measles returns and influenza spreads, confronting a crisis of trust that outlasted the pandemic that created it.
By the end of May 2026, Brazil had recorded 506 deaths tied to severe respiratory infections caused by influenza A and B. The number is troubling not only for its size, but for what it exposes about a country's preparedness — or the lack of it.
Among those deaths was Bryan, a thirteen-year-old from the interior of São Paulo state. What began as body aches and fatigue on March 30th became, within days, a fight for breath. He was seen at an urgent care clinic and sent home. When his condition worsened, he was rushed to an emergency room in Sorocaba, where Influenza A was confirmed. He was intubated. His heart stopped twice during hospitalization. On April 6th, it stopped a third time. His father, Eliseu, is still learning to live with the absence.
The 506 deaths represent a complicated picture. A full 27% were only confirmed in the final two weeks of May — not necessarily meaning they occurred then, but that overwhelmed laboratories identified them late. Meanwhile, 1,344 additional respiratory deaths this year have no confirmed viral cause, suggesting the real toll is higher. Case counts have also risen: 7,749 severe influenza cases through May, compared to 6,250 in the same period last year, with an unusually early seasonal surge in some regions.
Experts are clear that the virus itself has not changed significantly from 2025. What has changed is the population's defenses. Brazil's national flu vaccination campaign ended May 30th having reached only 38.5% of its target — 18.2 million of 47.4 million available doses administered — the lowest coverage since 2021. The goal had been 90%. Vaccine hesitancy, seeded during the COVID-19 pandemic and nourished by misinformation, has not receded. Measles, once eliminated in Brazil, has returned. The flu campaign has suffered the same collapse of confidence.
Influenza is not merely a respiratory illness. It can inflame blood vessel walls, dislodge arterial plaques, and trigger strokes or heart attacks. The H1N1 and H3N2 subtypes now circulating are known for rapid lung deterioration, particularly in children, the elderly, and the immunocompromised. H3N2 mutates frequently, making lasting immunity difficult to sustain. In closed environments, it spreads with ease.
Brazil's public health system offers a trivalent vaccine — protection against two type-A strains and one type-B — which experts say is sufficient for current circulating strains. The problem is not the vaccine's adequacy. The problem is that not enough people are choosing to receive it, and the consequences of that choice are now being counted in lives.
By late May, Brazil had recorded 506 deaths from severe acute respiratory infection linked to influenza A and B viruses. The number carries weight not just for its size but for what it reveals about the country's vulnerability to a virus that, in an earlier season, might have claimed fewer lives.
Eliseu Gomes de Souza Camargo, a production assistant, is still learning to live without his son. Bryan was thirteen. On March 30th, the boy complained of body aches and fatigue—the kind of complaint that sends a parent to the medicine cabinet, not the hospital. The next day brought fever. They took him to an urgent care clinic in the interior of São Paulo state. He was treated and sent home. But the pain in his back worsened. His breathing grew shallow. When they brought him to another emergency room in Sorocaba, he arrived depleted, gasping for air. Tests confirmed Influenza A. He was admitted, intubated. The disease moved fast. During his hospitalization, Bryan's heart stopped twice. On April 6th, it stopped a third time. His oxygen saturation had fallen beyond recovery. The medications no longer worked. There was nothing left to do.
Bryan's case sits within a larger crisis of numbers and choices. Of the 506 deaths recorded from January through May 2026, 136 of them—27 percent—were confirmed only in the final two weeks of May. This does not necessarily mean the deaths occurred then, but that the cause was identified then, a lag that speaks to overwhelmed laboratories and delayed diagnoses. In the same five-month window of 2025, Brazil had recorded 776 influenza-related deaths. The comparison is complicated by another fact: 1,344 respiratory deaths this year remain unidentified in their cause. They could be influenza. They could be COVID-19, rhinovirus, or respiratory syncytial virus. The true death toll is likely higher than the official count.
Cases themselves have climbed. Through May 2026, Brazil documented 7,749 cases of severe respiratory infection from influenza—256 from H1N1, 1,903 from H3N2, 4,892 from unsubtyped Influenza A, and 698 from Influenza B. In the same period last year, the country had recorded 6,250 cases. The increase is real, though doctors note that respiratory viruses naturally surge during autumn and winter, when dry air and cold temperatures drive people indoors and weaken the respiratory tract's defenses. What is unusual this year is the early arrival of that seasonal surge in some regions, bringing severe cases and hospitalizations sooner than expected.
The virus itself has not become more lethal, according to infectologists. The strains circulating in 2026 resemble those of 2025. What has changed is the population's readiness to meet them. On May 30th, Brazil's national flu vaccination campaign ended with a result that alarmed public health officials: only 38.5 percent of the target population had been vaccinated. The goal was 90 percent. The target population—children under six, the elderly, and pregnant women—received 18.2 million of the 47.4 million available doses. This is the lowest coverage rate since 2021. The reason, experts say, is vaccine hesitancy that took root during the COVID-19 pandemic and has not loosened. Misinformation spread. People began to distrust vaccines. Measles, which had been eliminated from Brazil, has returned. The flu campaign suffered the same erosion of confidence.
Influenza A, particularly the H1N1 and H3N2 subtypes now circulating, demands attention because of its capacity to mutate and spread. H1N1 became known globally during the 2009 pandemic, when a swine-origin virus moved rapidly across the world. It causes severe lung inflammation and rapid respiratory decline, especially in children, the elderly, and the immunocompromised. H3N2 spreads with ease and hits the elderly hard, whose immune systems are already fragile. It mutates frequently, making it difficult for the body to maintain lasting immunity. In closed spaces—nursing homes, hospitals—it spreads quickly. Influenza B circulates almost exclusively among humans and mutates less often, but it too can hospitalize, can cause respiratory complications, can kill.
The virus can inflame the inner lining of blood vessels. A plaque of fat lodged in a vessel can break free, enter the bloodstream, travel to the brain and cause a stroke, or reach the heart and cause a heart attack. Influenza is not only a respiratory disease. It is a disease of the whole body in crisis.
Vaccination rates have fallen year after year, and this decline has caught the attention of public health specialists. Low vaccination rates allow the virus to circulate freely. They leave the population exposed. They lead to more infections, more hospitalizations, more deaths. Ana Catarina de Melo Araújo, the Health Ministry's coordinator for scientific incorporation and immunization, noted that the campaign prioritized the most vulnerable groups from the start—children, pregnant women, the elderly—yet still saw low uptake. The vaccine offered by Brazil's public health system is trivalent, protecting against three strains of influenza: two of type A and one of type B. A quadrivalent version exists in private clinics, protecting against four strains, but experts say the trivalent vaccine is sufficient. One of the strains the quadrivalent protects against, Yamagata, has not circulated since the pandemic ended. The trivalent is enough. But enough people have not chosen to receive it.
Citações Notáveis
The desinformation made many people distrust vaccines, and this has been happening since the pandemic when vaccination was set aside. Proof of this is measles, which was eradicated, but has returned to Brazil due to lack of vaccination.— Juliana Lapa, infectologist and member of the Brazilian Society of Infectology's Respiratory Infections Committee
The saturation dropped very much, and he no longer responded to medications. From that point on, we were certain we had already lost him.— Eliseu Gomes de Souza Camargo, father of Bryan, on his son's final hours
A Conversa do Hearth Outra perspectiva sobre a história
Why did Bryan's case progress so quickly? Was there something about his age that made him vulnerable?
Age alone doesn't explain it. What matters is the interaction between the virus and the host. Bryan had no known chronic illness, but influenza A—especially H1N1 and H3N2—can overwhelm even healthy young people. The virus causes severe inflammation in the lungs. His body's own immune response may have worked against him. And there's the timing: he didn't get vaccinated. If he had been, his body would have recognized the virus faster.
The vaccination rate is 38.5 percent. That's a staggering drop from the 90 percent target. What happened between 2021 and now?
The pandemic broke something in how people think about vaccines. COVID-19 vaccines became political. Misinformation spread online and took root. People who might have gotten their flu shot without thinking twice began to hesitate. They questioned whether vaccines were safe, whether they worked. That doubt didn't disappear when the pandemic ended. It lingered.
But the flu vaccine has been around for decades. Why would people suddenly distrust it?
Because trust, once fractured, is hard to repair. The pandemic made vaccines visible in a way they hadn't been before. It made them controversial. And once something becomes controversial, people start to question everything about it—even the things that were never in question before.
The article mentions that 27 percent of deaths were confirmed in the final two weeks. What does that lag mean for the actual crisis?
It means the system is overwhelmed. Labs are backed up. Hospitals are processing cases faster than they can identify causes. And it means some people who died may not have known what was killing them until it was too late. Early diagnosis could have changed outcomes for some of them.
Is the virus itself more dangerous this year, or is it just that fewer people are protected?
It's the latter. The virus hasn't changed in any fundamental way. What's changed is the shield around the population. With vaccination rates this low, the virus finds more people to infect. More infections mean more severe cases, more hospitalizations, more deaths. The virus hasn't become stronger. We've become weaker.